Literature DB >> 31230820

The value of surgical staging in patients with apparent early stage epithelial ovarian carcinoma.

E M Hengeveld1, P L M Zusterzeel2, H Lajer3, C K Høgdall3, M Rosendahl3.   

Abstract

OBJECTIVE: The value of surgical staging of apparent early stage epithelial ovarian carcinoma (EOC) is unclear. The aim of this study was to evaluate the importance of surgical staging on the stage of disease and treatment plan.
MATERIAL AND METHODS: All patients with apparent stage I EOC undergoing staging from 01/01/2005 to 30/06/2017 in all Danish hospitals and in the Radboud University Hospital Nijmegen, the Netherlands, were evaluated to identify the pathological findings responsible for upstaging and changes in treatment plans.
RESULTS: We included 1234 patients with apparent stage I EOC. The staging steps often missed were the biopsy from the right diaphragmatic surface (missed in 96.9% of all patients) and lymph node (LN) sampling or lymphadenectomy (missed in 65.5% of all patients). Upstaging occurred in 393 patients (31.8%) due to microscopic spread to both ovaries (0.8%); ovarian surface (5.8%); positive cytology (10.0%); fallopian tubes (3.1%), ovary (1.5%) and/or uterus serosa (1.2%); pelvic peritoneum (4.3%); LNs (4.7%); omentum (3.7%); abdominal peritoneum (0.6%) and right diaphragmatic surface (2.6%). Of the 393 upstaged patients, 138 (35.1%) had an altered treatment plan due to metastases found by surgical staging.
CONCLUSION: Staging was incomplete in most patients, mainly because a biopsy of the diaphragm was omitted. However, surgical staging led to adjuvant treatment in 35.1% of the upstaged patients. Peritoneal biopsies (para-colic gutters and right diaphragm) were of little value, since few patients had an adjustment of treatment plan due to these biopsies. Omitting these biopsies, in the absence of peritoneal abnormalities, is justifiable.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Early stage; Epithelial ovarian cancer; Surgical staging

Mesh:

Year:  2019        PMID: 31230820     DOI: 10.1016/j.ygyno.2019.06.006

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  5 in total

1.  Radiomics based on multisequence magnetic resonance imaging for the preoperative prediction of peritoneal metastasis in ovarian cancer.

Authors:  Xiao-Li Song; Jia-Liang Ren; Ting-Yu Yao; Dan Zhao; Jinliang Niu
Journal:  Eur Radiol       Date:  2021-05-04       Impact factor: 5.315

2.  Laparoscopic and Laparotomic Restaging in Patients With Apparent Stage I Epithelial Ovarian Cancer: A Comparison of Surgical and Oncological Outcomes.

Authors:  Yongxue Wang; Jie Yin; Yan Li; Ying Shan; Yu Gu; Ying Jin
Journal:  Front Oncol       Date:  2022-06-20       Impact factor: 5.738

3.  The Risk of Para-Aortic Lymph Node Metastases in Apparent Early Stage Ovarian Cancer.

Authors:  Nicolae Bacalbasa; Irina Balescu; Mihaela Vilcu; Simona Dima; Camelia Diaconu; Laura Iliescu; Alexandru Filipescu; Mihai Dimitriu; Iulian Brezean
Journal:  Medicina (Kaunas)       Date:  2020-03-03       Impact factor: 2.430

4.  Incomplete surgical staging in clinical early-stage ovarian cancer: guidelines versus daily practice.

Authors:  P Laven; J J Beltman; J E Bense; M A van der Aa; T Van Gorp; M C Vos; D Boll; Hgj Arts; N Reesink; J B Trimbos; Rfpm Kruitwagen
Journal:  Surg Open Sci       Date:  2021-10-14

5.  Surgical staging of apparent early-stage ovarian mucinous carcinoma.

Authors:  Zhen Yuan; Ying Zhang; Dongyan Cao; Keng Shen
Journal:  World J Surg Oncol       Date:  2022-09-24       Impact factor: 3.253

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.